作者
Anna K Kopec, Nikita Joshi, Keara L Towery, Karen M Kassel, Bradley P Sullivan, Matthew J Flick, James P Luyendyk
发表日期
2014/11/1
期刊
Journal of Pharmacology and Experimental Therapeutics
卷号
351
期号
2
页码范围
288-297
出版商
American Society for Pharmacology and Experimental Therapeutics
简介
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of obesity and metabolic syndrome. Robust coagulation cascade activation is common in obese patients with NAFLD. We identified a critical temporal relationship between thrombin generation and the manifestation of hepatic steatosis, inflammation, and injury in C57BL/6J mice fed a high-fat diet (HFD) for 1, 2, and 3 months. Mice fed a HFD exhibited dramatic increases in hepatocellular injury and inflammation over time. Hepatic fibrin deposition preceded an increase in serum alanine aminotransferase, and the most dramatic changes in liver histopathology occurred in conjunction with a detectable increase in plasma thrombin-antithrombin levels at 3 months. To directly determine whether thrombin activity promotes NAFLD pathogenesis, mice were fed a HFD and simultaneously treated with the direct thrombin inhibitor dabigatran etexilate for 3 …
引用总数
2015201620172018201920202021202220232024285478109104
学术搜索中的文章
AK Kopec, N Joshi, KL Towery, KM Kassel, BP Sullivan… - Journal of Pharmacology and Experimental …, 2014